These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 18235084)
1. Products of 12/15-lipoxygenase upregulate the angiotensin II receptor. Xu ZG; Yuan H; Lanting L; Li SL; Wang M; Shanmugam N; Kato M; Adler SG; Reddy MA; Natarajan R J Am Soc Nephrol; 2008 Mar; 19(3):559-69. PubMed ID: 18235084 [TBL] [Abstract][Full Text] [Related]
2. 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance. Xu HZ; Cheng YL; Wang WN; Wu H; Zhang YY; Zang CS; Xu ZG Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164093 [TBL] [Abstract][Full Text] [Related]
3. Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy. Xu ZG; Li SL; Lanting L; Kim YS; Shanmugam N; Reddy MA; Natarajan R Kidney Int; 2006 Feb; 69(3):512-9. PubMed ID: 16514433 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy. Yuan H; Reddy MA; Deshpande S; Jia Y; Park JT; Lanting LL; Jin W; Kato M; Xu ZG; Das S; Natarajan R Antioxid Redox Signal; 2016 Mar; 24(7):361-75. PubMed ID: 26492974 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli. Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735 [TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli. Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232 [TBL] [Abstract][Full Text] [Related]
7. Roles of 12-Lipoxygenase and Its Interaction with Angiotensin II on p21 and p27 Expression in Diabetic Nephropathy. Zhang YY; Wang WN; Su SS; Chen B; Sun WX; Wu H; Cheng YL; Xu ZG Nephron; 2019; 142(1):61-70. PubMed ID: 30677774 [TBL] [Abstract][Full Text] [Related]
8. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Reddy MA; Adler SG; Kim YS; Lanting L; Rossi J; Kang SW; Nadler JL; Shahed A; Natarajan R Am J Physiol Renal Physiol; 2002 Nov; 283(5):F985-94. PubMed ID: 12372774 [TBL] [Abstract][Full Text] [Related]
9. Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells. Kim YS; Xu ZG; Reddy MA; Li SL; Lanting L; Sharma K; Adler SG; Natarajan R J Am Soc Nephrol; 2005 Feb; 16(2):352-62. PubMed ID: 15615821 [TBL] [Abstract][Full Text] [Related]
10. p16ink4a Expression Is Increased through 12-Lipoxygenase in High Glucose-Stimulated Glomerular Mesangial Cells and Type 2 Diabetic Glomeruli. Zhang YY; Guo QY; Wu MY; Zang CS; Ma FZ; Sun T; Wang WN; Miao LN; Xu ZG Nephron; 2015; 130(2):141-50. PubMed ID: 26022507 [TBL] [Abstract][Full Text] [Related]
11. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice. Kim YS; Reddy MA; Lanting L; Adler SG; Natarajan R Kidney Int; 2003 Nov; 64(5):1702-14. PubMed ID: 14531803 [TBL] [Abstract][Full Text] [Related]
12. Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages. Wen Y; Gu J; Vandenhoff GE; Liu X; Nadler JL Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1933-8. PubMed ID: 18296557 [TBL] [Abstract][Full Text] [Related]
13. Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes. Yuan H; Lanting L; Xu ZG; Li SL; Swiderski P; Putta S; Jonnalagadda M; Kato M; Natarajan R Am J Physiol Renal Physiol; 2008 Aug; 295(2):F605-17. PubMed ID: 18562637 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway. Scheidegger KJ; Butler S; Witztum JL J Biol Chem; 1997 Aug; 272(34):21609-15. PubMed ID: 9261183 [TBL] [Abstract][Full Text] [Related]
15. 12-Lipoxygenase as a key pharmacological target in the pathogenesis of diabetic nephropathy. Dong C; Liu S; Cui Y; Guo Q Eur J Pharmacol; 2020 Jul; 879():173122. PubMed ID: 32333927 [TBL] [Abstract][Full Text] [Related]
16. The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects. Reddy MA; Thimmalapura PR; Lanting L; Nadler JL; Fatima S; Natarajan R J Biol Chem; 2002 Mar; 277(12):9920-8. PubMed ID: 11786549 [TBL] [Abstract][Full Text] [Related]
17. Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells. Reddy MA; Sahar S; Villeneuve LM; Lanting L; Natarajan R Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):387-93. PubMed ID: 19095999 [TBL] [Abstract][Full Text] [Related]
18. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells. Limor R; Sharon O; Knoll E; Many A; Weisinger G; Stern N Am J Hypertens; 2008 Feb; 21(2):219-23. PubMed ID: 18202670 [TBL] [Abstract][Full Text] [Related]